Former ArthroCare (NSDQ:ARTC) executive John Raffle changed his plea to guilty last month, admitting to charges that he took part in a scheme to artificially inflate ARTC stock prices by misleading investors.
Orthopedics
Welcome to MassDevice's Orthopedics Hub, your resource for the latest in orthopedic news. Stay informed about the innovations and business news shaping the ortho device industry.
🦴 Narrow your focus with these categories:
Implants | Metal-on-Metal | Spine
Here are the top orthopedic device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ The biggest stories from AAOS 2024
+ The 10 largest orthopedic device companies in the world
+ The ZimVie Tether helps kids with scoliosis — if they can get it in time
+ Could 2023 be a boom year for orthopedic devices?
+ The top orthopedic device news out of AAOS 2023
Latest Orthopedics News
DePuy warns surgeons on fracture risk in Limb Preservation System
The Hong Kong Department of Health issued a Safety Alert following DePuy Orthopaedics‘ discovery that part of its Limb Preservation System may fracture under pressure.
Stryker pulls spinal devices off the shelves following failure reports
MassDevice.com Q&A: K2M co-founder & CEO Eric Major
Revenues in the spine industry have been flat for several years now, with the largest players in the space reporting declines or low-single-digit growth.
Feds indict ex-ArthroCare CEO, CFO in $400M fraud scheme
Federal prosecutors in Texas indicted the former CEO and CFO of ArthroCare (NSDQ:ARTC) on 17 counts of conspiracy to commit fraud for their alleged roles in running a $400 million scheme designed to defraud investors.
Johnson & Johnson’s medical device business misses Q2 expectations
Biomet swings to Q4 black, pares fiscal 2013 losses
Biomet said it posted black ink during the 4th quarter and cut its losses for fiscal 2013, reporting a 1.0 % decline in large joint reconstruction sales.
The privately held medical device company, which is said to be considering an IPO or sale, is closely watched as a bellwether for the orthopedic market, which has been bedeviled in recent years by falling procedure volumes for hip and knee replacements.
KFx Medical lands a pair of wins in patent suit against Arthrex
KFx Medical won a pair of decisions in a patent infringement lawsuit against Arthrex over technology used to attach soft tissue to bone.
Zimmer hammers out a deal with SpineCraft for its Apex device
Appeals court nixes Synthes patent in spat with Smith & Nephew
Long-awaited ruling in Medtronic Infuse lawsuit could have ripple effect on industry
Federal pre-emption statutes have thus far stalled personal injury complaints over Medtronic’s (NYSE:MDT) troubled Infuse bone-growth protein, but new lawsuits may find their way to trial by claiming that the medtech titan is liable for injuries because it engaged in off-label marketing.